The 3D bioprinting market is rewriting the future of healthcare, with exponential growth driven by breakthroughs in organ printing, demand for personalized medicine, and technological convergence. Valued at $XX billion in 2023, the market is projected to expand at a 22.5% CAGR, reaching $XX billion by 2030, according to leading analysts. This surge reflects a global urgency to address organ...